Loading provider…
Loading provider…
Medical Oncology Physician in Westminster, CO
NPI: 1316924806Primary Practice Location
CENTURA HEALTH-ST ANTHONY NORTH HEALTH CAMPUS
14300 Orchard Pkwy, Westminster, CO
Primary Employer
San Medical Oncology
mountain.commonspirit.org
HQ Phone
Get MD Eric's Phone Numberphone_androidMobile
Get MD Eric's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CO State Medical License
CO State Medical License
2023 - 2027
TX State Medical License
1991 - 2024

American Board of Internal Medicine
Medical Oncology
Baylor College Of Medicine
bcm.edu
Medical School
Until 1990
Residency • Internal Medicine
1991 - 1993
University of Texas Health Science Center at Houston
Fellowship • Hematology and Medical Oncology
1994 - 1997
University of Texas Southwestern Medical Center
Residency • Internal Medicine
1990 - 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 90 | 183 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 54 | 65 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 16 | 30 |
A New Immunotherapy Drug Creates a Watershed for the Surgical Pathologist's Role in Patient Care.
Authors: Philip Cagle, Eric Bernicker
Publication Date: 2015-10-31
Authors: Eamonn Quigley
Journal: J Thorac Oncol
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, DRUG: Gemcitabine Hydrochloride, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, DRUG: Pemetrexed Disodium, PROCEDURE: Echocardiography Test, OTHER: Observation Activity
Lead Sponsor: Immunocore Ltd
Intervention / Treatment: BIOLOGICAL: Pembrolizumab, BIOLOGICAL: Ipilimumab, DRUG: Dacarbazine, BIOLOGICAL: IMCgp100
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Pembrolizumab, DRUG: Canakinumab